-
Revolutionary 1.5B Router Model Surpasses Accuracy Without Retraining
Read more: Revolutionary 1.5B Router Model Surpasses Accuracy Without RetrainingThe race to build smaller, faster, and more cost-efficient AI models has taken a leap forward with a new innovation that has stunned both researchers and enterprise leaders. In early 2025, a new 1.5 billion parameter “router model” has emerged and achieved an unprecedented 93% accuracy rate — without undergoing expensive and resource-intensive retraining. Originally…
-
AI Impersonation Scandal: Marco Rubio’s Identity at Risk
Read more: AI Impersonation Scandal: Marco Rubio’s Identity at RiskWhen the news broke in July 2025 that U.S. Senator Marco Rubio had fallen victim to an advanced AI impersonation scam, it became immediately clear that the age of deepfake political manipulation had crossed a significant threshold. According to a detailed report by CNN, a hyper-realistic AI-generated video featuring Rubio making false foreign policy declarations…
-
AI Venture Funding Soars in Q2 2025 Amid Capital Shift
Read more: AI Venture Funding Soars in Q2 2025 Amid Capital ShiftThe pace of artificial intelligence (AI) innovation surged to new heights in the second quarter of 2025, with venture capital (VC) investments in AI companies reaching their highest levels since the beginning of the decade. According to Crunchbase News, global venture funding touched $79 billion in Q2 2025, up 16% from the previous quarter and…
-
Capital One’s Multi-Agent AI: Transforming Enterprise Workflows
Read more: Capital One’s Multi-Agent AI: Transforming Enterprise WorkflowsCapital One has emerged as one of the vanguards of enterprise AI innovation by deploying multi-agent systems purpose-built to orchestrate complex business workflows. In early 2025, the financial giant unveiled key progress publicized through publications like VentureBeat, showing how its internal AI innovation lab is using Large Language Models (LLMs) in tandem with domain-specific agents…
-
AI-Designed Drugs: Isomorphic Labs Initiates Clinical Trials
Read more: AI-Designed Drugs: Isomorphic Labs Initiates Clinical TrialsIn a milestone moment that may reshape the future of pharmaceuticals, Isomorphic Labs, a drug discovery company launched by DeepMind, has taken a leap from theoretical biology to clinical application. As of early 2025, the company announced it is initiating Phase 1 clinical trials for its first artificial intelligence (AI)-designed drug candidates. This marks a…
-
Investors Flock to AI-Driven Fashion Startups
Read more: Investors Flock to AI-Driven Fashion StartupsIn 2025, artificial intelligence continues to reshape industries, and the fashion sector is emerging as one of the most unlikely yet dynamic frontiers. Driven by advancements in generative AI, predictive modeling, and hyper-personalization, AI-driven fashion startups are attracting considerable investor interest globally. VCs and investors are eager not only due to the potential for fast-paced…
The Minimal Blogger
Artificial Intelligence, Investing, Commerce and the Future of Work
Contact
abel.circle@consultancycircle.com
Copyright 2025 | A WordPress Theme By SuperbThemes